Exagen (XGN) Cash from Financing Activities (2018 - 2026)
Exagen filings provide 9 years of Cash from Financing Activities readings, the most recent being -$62000.0 for Q1 2026.
- On a quarterly basis, Cash from Financing Activities rose 3.12% to -$62000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $24.4 million, a 3997.45% increase, with the full-year FY2025 number at $24.4 million, up 3785.52% from a year prior.
- Cash from Financing Activities hit -$62000.0 in Q1 2026 for Exagen, up from -$384000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $21.9 million in Q2 2025 to a low of -$10.2 million in Q2 2023.
- Median Cash from Financing Activities over the past 5 years was -$108000.0 (2023), compared with a mean of $740529.4.
- Biggest five-year swings in Cash from Financing Activities: tumbled 3779.55% in 2023 and later skyrocketed 9804.87% in 2025.
- Exagen's Cash from Financing Activities stood at -$173000.0 in 2022, then fell by 27.17% to -$220000.0 in 2023, then grew by 1.82% to -$216000.0 in 2024, then crashed by 77.78% to -$384000.0 in 2025, then surged by 83.85% to -$62000.0 in 2026.
- The last three reported values for Cash from Financing Activities were -$62000.0 (Q1 2026), -$384000.0 (Q4 2025), and $2.9 million (Q3 2025) per Business Quant data.